Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET
Category: Infectious Diseases
Pharmaceutical company Gilead's stock price rose to $72.73 per share, the highest it's been in nearly 20 years, after its hepatitis C treatment successfully treated patients involved in an experimental trial, reported Bloomberg.
Gilead is one of several companies racing to find a treatment for hepatitis C that works quickly and without side effects. Rival manufacturers Achillion Pharmaceuticals and Vertex Pharmaceuticals showed a decline in the marketplace - 20 percent and 5.1 percent, respectively - after the news of Gilead's success broke, according to Bloomberg.
"In 2013, given that Gilead's regimen has the best overall profile (efficacy, safety, convenience), we anticipate a significant amount of warehousing," wrote Ravi Mehrotra, an analyst for Credit Suisse, in a research note.
Another pharmaceutical company, Abbott, showed signs of success in developing a treatment for the virus. By combining three drugs along with a booster known as ritonavir, 87 percent of the subjects involved in its 12-week trial were cleared of the disease, and another combination of its drugs, which involved the hepatitis C medication ribavirin, cured 97 percent of the patients. Gilead's treatment regimen has the advantage though because it uses fewer pills, reported Bloomberg.
Hepatitis C, which can be detected with blood testing, is usually contracted through contact with blood. According to the National Institutes of Health (NIH), some symptoms include abdominal pain, dark urine, fever, nausea and a loss of appetite.
Traditional treatment for the disease seeks to eliminate the virus from the blood in order to decrease the chance of developing liver cancer and cirrhosis of the liver.
Some prevention methods that the NIH recommends include not taking intravenous drugs, and for healthcare workers to always be cautious when handling blood and other bodily fluids. Sexual partners should also be screened for the disease, even though the likelihood of transmitting hepatitis C via intercourse is low.
Related Articles from Private MD:
News Categories:Advanced Lipid Treatment I Allergy Testing Anemia and RBC disorders Autoimmune Diseases Bariatric Lab Testing Blood and Blood Diseases Breast Cancer Detection and Tumor Markers Celiac Disease Testing Chlamydia Coagulation and blood clotting disorders Colon Diabetes DNA, Paternity and Genetic testing Drug Screening Environmental Toxin Testing Female Specific Tests Gastrointestinal Diseases General Health General Wellness Heart Health and Cholesterol Herpes HIV HIV monitoring/Treatment/Testing/Post Diagnos Hormones and Metabolism Infectious Diseases Infertility Testing-Male Infertitlity Hormone Testing Kidney Diseases Leukemia and WBC disorders Liver Liver Diseases Lyme Disease Male Specific Tests Menopause/Peri-Menopausal Diagnosis Musculoskeletal Diseases Organ Specific Testing Ovarian Prostate Sexually Transmitted Diseases Thyroid Diseases Transgender Hormone Testing-female to male Transgender Hormone Testing-Male to Female Vitamin D Deficiency-Diagnosis and Treatment
Visit the Health News Archive: Click Here
Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.Back to top